The 20th International Prostate Cancer Update
Wednesday, January 27, 2010 - Saturday, January 30, 2010
Cascade Conference Center
Vail, Colorado
Click on the Presentations to Download PDFs
Thursday, January 28
|
SESSION I: PREVENTION/SCREENING
Chair: Per-Anders Abrahamsson, MD, PhD – Malmo, Sweden
|
Welcome and Introduction
E. David Crawford, MD – Denver, CO |
Biomarkers for Prostate Cancer: Part 1
M. Scott Lucia, MD – Denver, CO |
Chemoprevention Trials: What Do The Results Mean?
Leonard G. Gomella, MD – Philadelphia, PA |
European View of Chemoprevention: ERSPC Trial
Per-Anders Abrahamsson, MD, PhD - Malmo, Sweden |
Watchful Waiting versus Chemoprevention
William Catalona, MD – Chicago, IL |
Pathology of Prostate Cancer: High-grade PIN
M. Scott Lucia, MD – Denver, CO |
Friday, January 29
|
SESSION II: LOCALIZED DISEASE
Chair: E. David Crawford, MD – Denver, CO
|
PSA and Isoforms for Prostate Cancer
Alan W. Partin, MD, PhD – Baltimore, MD |
Expectant Management: The Johns Hopkins Program Experience
Alan W. Partin, MD, PhD – Baltimore, MD |
Data on Localized Disease: The VA Perspective PART 1 | PART 2 | PART 3 | PART 4 | PART 5
Robert E. Donohue, MD – Denver, CO |
The Economics and Effectiveness of HIFU and Robotics
James A. Eastham, MD – New York, NY |
The Emerging Role of Options for Targeted Therapy PART 1 | PART 2 | PART 3 | PART 4 | PART 5
E. David Crawford, MD – Denver, CO |
The Role of Focal Therapy in Treating Localized Prostate Cancer PART 1 | PART 2 | PART 3
Frans M.J. Debruyne, MD, PhD – Arnhem, The Netherlands
|
SESSION III: ISSUES WITH HORMONE DEPRIVATION
Chair: E. David Crawford, MD – Denver, CO
|
The 30th Anniversary of Leuprolide: Where Are We Now?
Marc B. Garnick, MD – Boston, MA |
An Update on GnRH Agonsists and Antagonists
Frans M.J. Debruyne, MD, PhD - Arnhem, The Netherlands |
Treatment of Skeletal Related Issues
Matthew R. Smith, MD, PhD – Boston, MA |
What Are the Major Issues with Hormone Replacement Therapy?
Abraham Morgentaler, MD – Boston, MA |
Saturday, January 30 |
SESSION IV: TREATMENT OF ADVANCED AND CASTRATION-RESISTANT DISEASE
Chair: Daniel P. Petrylak, MD – New York, NY
|
Immunotherapy with Vaccines
Neal D. Shore, MD – Myrtle Beach, SC |
Update on Clinical Trials in CRPC
Daniel P. Petrylak, MD – New York, NY |
Effective Testosterone Suppression for Prostate Cancer
E. David Crawford, MD – Denver, CO |
Biology of Prostate Cancer Metastases PART 1 | PART 2
Paul H. Lange, MD – Seattle, WA |
| Group Discussion/Case Studies LANGE | PETRYLAK |
|
HIGHLIGHTS
Learn more...